EMMA International

EMMA International EMMA International is a leading global consulting firm for the medical device, pharmaceutical, biotechnology, combination products, and diagnostics industries.

With a focus on quality, regulatory and compliance services, EMMA International helps ensure your products advance seamlessly from concept to approval. When you need specialized services, such as building a Quality Management System (QMS) or remediation of major gaps and deficiencies, EMMA’s experienced consultants will guide you toward a practical solution. We won’t leave you with a foreign proce

ss or system that ultimately becomes unworkable. Our mission is to provide significant value to your operations and exceed your expectations. As your regulatory partner, EMMA works within your corporate culture and alongside your team. While you focus on innovation and development, you can trust us to take care of the heavy lifting that results in permanent, meaningful improvements.

New Blog Alert!Emerging technologies such as artificial intelligence, machine learning, cloud computing, automation, and...
06/05/2026

New Blog Alert!

Emerging technologies such as artificial intelligence, machine learning, cloud computing, automation, and connected manufacturing systems are transforming the life sciences industry at an unprecedented pace.

While these innovations offer significant opportunities to improve efficiency, scalability, and operational visibility, they also introduce new challenges surrounding validation, governance, data integrity, and regulatory compliance.

In our latest blog, we explore how risk-based validation strategies can help organizations modernize validation frameworks, prioritize critical system functions, and maintain compliance readiness while supporting ongoing digital transformation initiatives.

Read more from our team of experts: https://emmainternational.com/risk-based-validation-strategies-for-emerging-technologies/

On behalf of EMMA International, we proudly recognize World Environment Day, and the global efforts dedicated to protect...
06/05/2026

On behalf of EMMA International, we proudly recognize World Environment Day, and the global efforts dedicated to protecting our planet and promoting sustainable practices across industries.

Environmental stewardship plays a critical role in the life sciences sector, where innovation, quality, and sustainability must work together to support long term public health and environmental responsibility.

Today, we celebrate the individuals, organizations, and initiatives helping create a more sustainable future for generations to come.

New Blog Alert!Growth is a priority for many pharmaceutical, biotechnology, and medical device organizations, but scalin...
06/04/2026

New Blog Alert!

Growth is a priority for many pharmaceutical, biotechnology, and medical device organizations, but scaling operations in a regulated environment requires more than increasing capacity and resources.

As organizations expand manufacturing, enter new markets, adopt digital technologies, and grow their supplier networks, maintaining compliance, quality, and inspection readiness becomes increasingly complex.

In our latest blog, we explore how organizations can successfully scale operations without sacrificing compliance by strengthening quality systems, modernizing infrastructure, improving governance, and building scalable operational frameworks that support sustainable long-term growth.

Read more from our team of experts: https://emmainternational.com/scaling-operations-without-sacrificing-compliance/

New Blog Alert!As life sciences supply chains become increasingly global, organizations face growing challenges related ...
06/03/2026

New Blog Alert!

As life sciences supply chains become increasingly global, organizations face growing challenges related to supplier oversight, quality consistency, data integrity, cybersecurity, and regulatory compliance.

Supplier qualification is no longer simply a procurement or quality function. It has become a strategic business capability that helps organizations strengthen supply chain resilience, reduce operational risk, and maintain long term compliance readiness.

In our latest blog, we explore the growing importance of supplier qualification, evolving regulatory expectations, and how risk-based qualification programs can help organizations better manage supplier performance across complex global networks.

Read more from our team of experts: https://emmainternational.com/supplier-qualification-in-a-globalized-supply-chain/

New Blog Alert!As regulatory expectations continue to evolve across the global life sciences industry, organizations are...
06/02/2026

New Blog Alert!

As regulatory expectations continue to evolve across the global life sciences industry, organizations are facing increasing pressure to stay ahead of emerging requirements, inspection trends, digital transformation initiatives, and global compliance obligations.

In our latest blog, we explore the growing importance of Regulatory Intelligence and why proactive monitoring, analysis, and interpretation of regulatory developments have become critical for long-term success.

Learn how regulatory intelligence supports informed decision-making, strengthens compliance readiness, enhances risk management, and helps organizations navigate an increasingly complex global regulatory landscape.

Read more from our team of experts: https://emmainternational.com/importance-of-regulatory-intelligence/

06/01/2026

This Pride Month, EMMA International proudly celebrates the LGBTQ+ community and the diversity, authenticity, and perspectives that make our workplaces and communities stronger.

Innovation thrives when people feel empowered to bring their full selves to the table. We believe that fostering an environment of inclusion, respect, and belonging helps drive collaboration, creativity, and meaningful progress across the life sciences industry.

As we recognize Pride Month, we reaffirm our commitment to creating spaces where every individual is valued, supported, and given the opportunity to succeed.

Happy Pride Month from all of us at EMMA International. 🌈

New Blog Alert!As the development of ultra-rare disease therapies continues to evolve, regulatory pathways are adapting ...
06/01/2026

New Blog Alert!

As the development of ultra-rare disease therapies continues to evolve, regulatory pathways are adapting to address the unique challenges associated with limited patient populations and scarce clinical data.

In our latest blog, we explore the FDA’s Plausible Mechanism Pathway, an emerging regulatory approach that may help support the development and approval of treatments for ultra-rare diseases when traditional clinical evidence is difficult to obtain.

Learn how this pathway is shaping regulatory strategy, accelerating innovation, and creating new opportunities for patients with unmet medical needs.

Read more from our team of experts: https://emmainternational.com/ultra-rare-disease-therapies-fdas-plausible-mechanism-pathway/

New Blog Alert! The regulatory landscape across the life sciences industry is entering a new era shaped by data, digital...
05/28/2026

New Blog Alert! The regulatory landscape across the life sciences industry is entering a new era shaped by data, digital transformation, and advanced analytics. As pharmaceutical, biotechnology, and medical device companies generate increasingly large volumes of operational and clinical data, regulatory agencies are also evolving how they monitor compliance, assess risk, and oversee regulated activities.

Read more from our team of experts:
https://emmainternational.com/the-future-of-predictive-regulation/

Address

1248 Edgewood Avenue LL
Birmingham, MI
48009

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+12489874497

Alerts

Be the first to know and let us send you an email when EMMA International posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EMMA International:

Share